Literature DB >> 26660757

Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status.

J L Santos1, I Yévenes2, L R Cataldo2, M Morales2, J Galgani2, C Arancibia2, J Vega2, P Olmos2, M Flores2, J P Valderas3, F Pollak2.   

Abstract

Insulin secretion and insulin sensitivity indexes are related by hyperbolic functions, allowing the calculation of the disposition index (DI) as the product of the acute insulin response (AIR) and the insulin sensitivity index (Si) from intravenous glucose tolerance test (IVGTT). Our objective was to develop an oral-DI based on the oral glucose tolerance test (OGTT) and to assess its association with glucose tolerance status. This research is structured in three studies. Study 1: OGTT were performed in 833 non-diabetic Chilean women (18-60 years) without family history of diabetes mellitus. Study 2: an independent group of n = 57 non-diabetic (18-46 years) without family history of diabetes mellitus carried out an OGTT and an abbreviated IVGTT. Study 3: a sample of 1674 Chilean adults (18-60 years) with different glycaemic status performed an OGTT. An adequate statistical fit for a rectangular hyperbola was found between the area under the curve of insulin-to-glucose ratio (AUCI/G-R) and the Matsuda ISI-COMP index (study 1). The oral-DI derived as AUCI/G-R × ISI-COMP was previously termed insulin-secretion-sensitivity index-2 (ISSI-2). ISSI-2 significantly correlated with DI from IVGTT (rho = 0.34; p = 0.009) (study 2). ISSI-2 shows important differences across groups of subjects with different glycaemic status (study 3). We have confirmed that ISSI-2 replicates the mathematical properties of DI, showing significant correlations with DI from the abbreviated MM-IVGTT. These results indicate that ISSI-2 constitutes a surrogate measure of insulin secretion relative to insulin sensitivity and emphasizes the pivotal role of impaired insulin secretion in the development of glucose homeostasis dysregulation.

Entities:  

Keywords:  Diabetes; Disposition index; Glucose; Insulin

Mesh:

Substances:

Year:  2015        PMID: 26660757     DOI: 10.1007/s13105-015-0458-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  33 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

3.  Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.

Authors:  A Mari; A Tura; A Natali; M Laville; M Laakso; R Gabriel; H Beck-Nielsen; E Ferrannini
Journal:  Diabetologia       Date:  2010-01-09       Impact factor: 10.122

Review 4.  beta-cell failure in diabetes and preservation by clinical treatment.

Authors:  Bernardo L Wajchenberg
Journal:  Endocr Rev       Date:  2007-03-12       Impact factor: 19.871

5.  Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.

Authors:  Leona Plum; Leaque Ahmed; Gerardo Febres; Marc Bessler; William Inabnet; Elizabeth Kunreuther; Donald J McMahon; Judith Korner
Journal:  Obesity (Silver Spring)       Date:  2011-05-19       Impact factor: 5.002

6.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.

Authors:  Ravi Retnakaran; Sandy Shen; Anthony J Hanley; Vladimir Vuksan; Jill K Hamilton; Bernard Zinman
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

8.  Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function.

Authors:  Silke A Herzberg-Schäfer; Harald Staiger; Martin Heni; Caroline Ketterer; Martina Guthoff; Konstantinos Kantartzis; Fausto Machicao; Norbert Stefan; Hans-Ulrich Häring; Andreas Fritsche
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

9.  Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  Carlos Lorenzo; Lynne E Wagenknecht; Marian J Rewers; Andrew J Karter; Richard N Bergman; Anthony J G Hanley; Steven M Haffner
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 17.152

10.  Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Authors:  Kristina M Utzschneider; Ronald L Prigeon; Mirjam V Faulenbach; Jenny Tong; Darcy B Carr; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 19.112

View more
  12 in total

1.  Plasma lactate and leukocyte mitochondrial DNA copy number as biomarkers of insulin sensitivity in non-diabetic women.

Authors:  José L Santos; Luis R Cataldo; Cristián Cortés-Rivera; Carolina Bravo; Luis Díaz-Casanova; J Alfredo Martínez; Fermín I Milagro; José Galgani
Journal:  J Physiol Biochem       Date:  2019-03-13       Impact factor: 4.158

2.  Modifiable predictors of type 2 diabetes mellitus and roles of insulin resistance and β-cell function over a 6-year study and 30-year follow-up.

Authors:  X Shen; S He; J Wang; X Qian; H Wang; B Zhang; Y Chen; H Li; Y An; Q Gong; G Li
Journal:  J Endocrinol Invest       Date:  2022-10-11       Impact factor: 5.467

3.  Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.

Authors:  Shivraj Grewal; Andin Fosam; Liam Chalk; Arjun Deven; Mari Suzuki; Ricardo Rafael Correa; Jenny E Blau; Andrew Paul Demidowich; Constantine A Stratakis; Ranganath Muniyappa
Journal:  Endocrine       Date:  2021-01-18       Impact factor: 3.633

4.  Epigenome-wide association study in peripheral white blood cells involving insulin resistance.

Authors:  Ana Arpón; Fermín I Milagro; Omar Ramos-Lopez; M Luisa Mansego; José Luis Santos; José-Ignacio Riezu-Boj; J Alfredo Martínez
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

5.  Methylome-Wide Association Study in Peripheral White Blood Cells Focusing on Central Obesity and Inflammation.

Authors:  Ana Arpón; Fermín I Milagro; Omar Ramos-Lopez; Maria L Mansego; José-Ignacio Riezu-Boj; J Alfredo Martínez
Journal:  Genes (Basel)       Date:  2019-06-11       Impact factor: 4.096

6.  The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.

Authors:  Gilda E Ennis; Akshay Kohli; Erin M Jonaitis; Tobey J Betthauser; Jennifer M Oh; Chase E Taylor; Nathaniel Chin; Rebecca L Koscik; Bradley T Christian; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin
Journal:  Neurobiol Aging       Date:  2021-05-06       Impact factor: 5.133

7.  Association of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed meal.

Authors:  Mona Mashayekhi; Jessica R Wilson; Scott Jafarian-Kerman; Hui Nian; Chang Yu; Megan M Shuey; James M Luther; Nancy J Brown
Journal:  Diabetes Obes Metab       Date:  2020-10-22       Impact factor: 6.408

8.  Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake.

Authors:  Omar Ramos-Lopez; Jose I Riezu-Boj; Fermin I Milagro; J Alfredo Martinez
Journal:  Brain Behav       Date:  2018-07-11       Impact factor: 2.708

9.  Associations between olfactory pathway gene methylation marks, obesity features and dietary intakes.

Authors:  Omar Ramos-Lopez; Jose I Riezu-Boj; Fermin I Milagro; M Angeles Zulet; Jose L Santos; J Alfredo Martinez
Journal:  Genes Nutr       Date:  2019-04-25       Impact factor: 5.523

10.  PPARGC1A Gene Promoter Methylation as a Biomarker of Insulin Secretion and Sensitivity in Response to Glucose Challenges.

Authors:  José L Santos; Bernardo J Krause; Luis Rodrigo Cataldo; Javier Vega; Francisca Salas-Pérez; Paula Mennickent; Raúl Gallegos; Fermín I Milagro; Pedro Prieto-Hontoria; J Ignacio Riezu-Boj; Carolina Bravo; Albert Salas-Huetos; Ana Arpón; José E Galgani; J Alfredo Martínez
Journal:  Nutrients       Date:  2020-09-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.